In Vitro and In Vivo evaluation of hydroxypropylmethyl cellulose phthalate capsules
Keywords:
Capsule, hydroxypropylmethylcellulose phthalate (HPMCP), gamma scintigraphy, radiolabelling, technetium-99mAbstract
The aim of this study was to develop a novel HPMCP capsule. The HPMCP capsule containing99mTc-DTPA and lactose was evaluated in in vitro and in vivo studies. First of all, the HPMCP capsules were prepared and characterized with lenght and diameter size, brittleness facility, moisture content and microbiological test. In vitro resistance and solubility studies of prepared capsules were tested at pH 1.2 and pH 7.4 buffers. The radiolabeled HPMCP capsules were administrated to fasted volunteers. The disintegration times and positions of capsules were recorded by using gamma scintigraphy. In vitro studies showed that HPMCP capsules were gastro resistant for 2 h at pH 1.2 and dissolved at pH 7.4 in 20-25 minutes. The radiolabeled capsules did not disintegrate in stomach whereas disintegrated in intestines. In conclusion, it was found that, the prepared HPMCP capsules can be an alternative to the hard gelatine capsules and used for intestinal targeting.
References
Cole ET, Scoot AR, Alyson LC, Wilding IR,
Petereit HU, Schminke C, Beckert T, Cade
D. Enteric coated HPMC capsules designed
to achieve intestinal targeting. Int. J. Phar.
;231:83-95.
Leopold CS. Coated dosage forms for colonspecific drug delivery. Pharm. Sci. Technol.
Today 2:197.
Chourasia MK, Jain SK. Pharmaceutical
approaches to colon targeted drug delivery
systems, J. Pharm. Sci. 2003;6:1:33-66.
Kotke MK, Rudnic EM. Tablet Dosage
Forms, Modern Pharmaceutics, (Editor
Banker GS and Rhodes CT, Marcel Dekker,
New York and Basel, 1990.
Lin SY and Kawashima Y. "Drug release
from tablets containing cellulose acetate
phthalate as an additive or enteric-coating
material. Pharm. Res. 1987;4:70-4.
Paul DR and Harris FW, Controlled Release
Polymeric Formulations, (UMI, American
Chemical Society, Washington, DC, 1976.
Robinson JR and Lee VHL, Controlled
Drug Delivery. Fundamentals and
Applications .Marcel Dekker, New York
and Basel, 1987.
Omar, Samia, Aldosari, Basmah, Refai,
Hanan and Gohary, Omaimah Al. Colonspecific drug delivery for mebeverine
hydrochloride. Journal of Drug Targeting,
;15:691-700.
Sinha VR, Kumria R. Polysaccharides in
colon-specific drug delivery. Int J Pharm
;224:19–38.
Ogura T, Furuya Y, Matsuura S. HPMC
capsules – an alternative to gelatin. Pharm.
Technol. Eur. 1998;11:32-42.
Saleem A, Aboagye EO, Price MP. In vivo
monitoring of drugs using radiotracer
techniques. Advanced Drug Delivery
rewiews. 2000;41:21-39.
Yang L, Chu JS, Fix JA. Colon-specific
drug delivery: new approaches and in
vitro/in vivo evaluation, International
Journal of Pharmaceutics. 2002;235:1-15.
Kirilmaz L. Two new suggestions for
pharmaceutical dosage forms:
ethylcellulose and cellulose acetate
phthalate capsules. S.T.P. Pharma Sciences,
;3:374-378.
Senjkovic R, Becirevic M, Rudic J.
Pharmaceutical availability of papaverine
hydrochloride from spray-dried products
prepared with cellulose phthalates.
Pharmazie. 1990;45:749-51.
Jones BE, Capsule Standards, Chapter 5,
Hard capsules, Development and
Technology, Edit by K. Rıdgway, The
Pharmaceutical Press, London, 1987;pg 66.
Ashford M, Fell JT. Targeting drugs to the
colon: Delivery systems for oral
administration. J. Drug Target. 1994;2:242-
